Navigation Links
Twenty New Abstracts on Oral Xeloda(R) (capecitabine) Featured at the 31st San Antonio Breast Cancer Symposium
Date:12/9/2008

ochemical staining (IHC), is associated with a clinical response of the primary tumor in women receiving neoadjuvant docetaxel-capecitabine chemotherapy for locally advanced breast cancer (Lead Author: Jeffrey Ross)

-- Dec. 14, 7:00 to 9:00 a.m., [Poster No. 6091], Survival outcome is similar for first-line chemotherapy with capecitabine or taxane for metastatic breast cancer (Lead Author: Gretchen Kimmick)

The majority of the 15 ex-U.S. abstracts being presented highlight Xeloda as a cornerstone of combination treatment. The remaining Xeloda abstract is a non-Roche sponsored study.

About XELODA (capecitabine)

Xeloda is the only FDA-approved oral chemotherapy for both metastatic breast cancer and adjuvant and metastatic colorectal cancer. Inactive in pill form, Xeloda is enzymatically activated within the body; when it comes into contact with a naturally occurring protein called thymidine phosphorylase, or TP, Xeloda is transformed into 5-FU, a cytotoxic (cell-killing) drug.

Because many cancers have higher levels of TP than does normal tissue, more 5-FU is delivered to the tumor than to other tissue.

A clinically important drug interaction between Xeloda and warfarin has been demonstrated; altered coagulation parameters and/or bleeding and death have been reported. Clinically significant increases in prothrombin time (PT) and INR have been observed within days to months after starting Xeloda, and infrequently within one month of stopping Xeloda. For patients receiving both drugs concomitantly, frequent monitoring of INR or PT is recommended. Age greater than 60 and a diagnosis of cancer independently predispose patients to an increased risk of coagulopathy.

Xeloda is contraindicated in patients who have a known hypersensitivity to 5-fluorouracil, and in patients with known dihydropyrimidine dehydrogenase (DPD) deficiency. Xeloda is contraindic
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. State Medicaid Programs to Spend $1.6 Trillion on Long-Term Care over the Next Twenty Years
2. Twenty of Americas Most Promising Scientists Selected as 2008 Pew Scholars in the Biomedical Sciences
3. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
4. BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
5. Medco CEO to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
6. ev3 Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
7. Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008
8. Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer
9. The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer
10. Top Twenty Health Plan Websites Named by TheRatingsGuy.com
11. Memory Pharmaceuticals Announces Six Abstracts Accepted for Presentation at Society for Neuroscience Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 2014 Mirena lawsuits ( http://www.mirenalawsuit2014.com/ ... New Jersey’s Bergen County Superior Court, where the ... there is quickly approaching 1,300, Bernstein Liebhard LLP ... shows 1,293 lawsuits now pending in the consolidated ... complications resulting from spontaneous migration of the birth ...
(Date:11/28/2014)... 28, 2014 Miami's Plastic Surgery of ... Practice founder Dr. Jeffrey Epstein is excited ... a groundbreaking WordPress platform, the site is uniquely designed ... Currently, up to 75% of all prospective rhinoplasty patients ... people are logging on with smartphones, tablets, and laptops, ...
(Date:11/28/2014)... 2014 Secura Consultants, based in ... marketing organizations in the country focused on delivering ... marketplace. Secura Consultants is proud to offer complimentary ... Group, a leading global financial company. , Many ... the ownership interest comes the need for business ...
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this ... as gastroesophageal reflux disease (GERD) -- a few steps may ... nose and throat specialist at Lenox Hill Hospital in New ... on Thanksgiving: Pace yourself. Rather than ... throughout the day. It,s also a good idea to have ...
(Date:11/28/2014)... Texas (PRWEB) November 28, 2014 ... prediabetes testing and treatment, helped employees learn their ... on-site diabetes blood screening at a local school ... Diabetes @ Work initiative. , As the ... Work program , PreDiabetes Centers is co-hosting diabetes-prevention ...
Breaking Medicine News(10 mins):Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... MECHANICSBURG, Pa., Nov. 12 Select Medical Corporation,("Select") ... Inc. ("CORA"),have mutually agreed to terminate the Agreement ... on October 1, 2007, pursuant to which Select ... Medical Corporation is a leading operator of specialty ...
... biologists at Jeffersons Kimmel Cancer Center in Philadelphia ... some potentially dangerous autoinflammatory diseases. In doing so, ... of the disease process, but have also identified ... arthritis to cancer. , Reporting in the journal ...
... 13, 8:00 EST -, SOUTH SAN FRANCISCO, ... a biopharmaceutical company, and Raven,biotechnologies, inc., a privately ... therapeutics (MAbs) for treating cancer, announced,today that their ... merger agreement. The merger is expected to create ...
... 12 Northwestern University,announced today that it ... study for women with locally recurrent or ... the efficacy of Nexavar(R),(sorafenib) tablets in combination ... cancer. Nexavar, an oral multi kinase inhibitor ...
... Letters to HHS Office of Inspector General and,Congressman ... Today, the American,Association for Homecare vigorously disputed the ... a basis for setting reimbursement rates for,power wheelchairs ... The Association outlined its concerns in letters sent ...
... found , MONDAY, Nov. 12 (HealthDay News) -- Correcting ... of life, it may lower risks for depression, U.S. ... Alabama at Birmingham studied 78 nursing home residents, 55 ... an eye exam and 64 residents who received eyeglasses ...
Cached Medicine News:Health News:Jefferson scientists uncover key pathway, potential drug targets in autoinflammatory disease 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 2Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 3Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 4Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 5Health News:VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement 6Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 2Health News:Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study 3Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 2Health News:American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare 3Health News: Eyeglasses Upgrade Helps Elderly Battle Depression 2
(Date:11/28/2014)... , Nov. 28, 2014 Aratana Therapeutics, ... focused on the licensing or acquisition, development and commercialization ... companion animals, today announced that it will present at ... to be held December 2-3, 2014, at the New ... . Steven St. Peter , M.D., ...
(Date:11/28/2014)... 2014 Chinese magnesium alloy maker DongGuan Eontec ... magnesium alloy bone fixation screw has received Chinese regulatory ... and instrument and that the company acknowledges receipt of ... Science and Technology Daily journalists Wang Xiangming ... and founder, Professor Li Yangde , has been ...
(Date:11/27/2014)... 2014 Hovione announced today it ... with the U.S. Food and Drug Administration (FDA). This ... improved drug delivery options for established drugs. ... formulation using a new patented crystalline base form of ... prescribed oral antibiotics for acne. Currently, there are no ...
Breaking Medicine Technology:Aratana Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Hovione Files its First Investigational New Drug Application With the FDA 2
... in a row, A dvertising ... www.eveo.com ) as the #1 Independent Digital Healthcare Agency in the ... d A ge rankings, ... (Photo:   http://photos.prnewswire.com/prnh/20110516/SF03150 ) (Logo:   http://photos.prnewswire.com/prnh/20100630/SF29260LOGO-a ...
... enhanced the capability of its GlideScope® Cobalt AVL video ... designed for small children.  The new Stat is a ... patents weighing from 10 to 28 kilograms, extending the ... kilograms) through patients weighing up to 28 kilograms. ...
Cached Medicine Technology:Eveo Ranked #1 Independent Digital Healthcare Agency in U.S. 2nd Year in a Row 2Verathon Extends Range of GlideScope Video Laryngoscope With New Single Use - GVL 2.5 Stat for Small Children 2
Stab incision blades color coded for simple and accurate identification...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
30, 6.0mm from end...
Medicine Products: